Quantcast
Last updated on April 21, 2014 at 9:28 EDT

Latest bloating Stories

2010-06-15 08:49:00

CABOT, Vt., June 15/PRNewswire/ -- Nearly 50 million Americans suffer from lactose intolerance* - the inability to digest lactose, a sugar found in many milk products that often leads to painful stomach cramps, bloating and other discomfort. With so many people affected by lactose intolerance, and in recognition of June as National Dairy Month, the Farm Family owners of Cabot Creamery Cooperative are offering two free webinars to help lactose intolerance sufferers cope with the effects of...

2010-06-03 07:00:00

SAN DIEGO, June 3 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial...

2010-05-19 06:00:00

PRINCETON, N.J., May 19 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that the United States Patent Office (USPTO) has issued a patent (US 7,704,985) entitled "Treatment of Irritable Bowel Syndrome and Related Bowel Diseases." The patent claims the use of beclomethasone dipropionate (BDP) to treat irritable bowel syndrome (IBS), a painful gastrointestinal condition that affects...

2010-05-09 08:49:08

Lipoma of the small intestine is a benign tumor of mesenchymal origin which is mostly found by chance during gastrointestinal investigation. Invaginations account for 2/3 of small bowel occlusion caused by up to 80% of tumors and the lipoma is the most frequent benign tumor that causes invagination in its submucous polypoid and it is in more or less scissile form. However, multiple lipomas within the intestinal duplication canal as a predominant cause of partial intestinal obstruction is an...

2010-05-04 12:59:44

Results confirm earlier Cedars-Sinai studies showing effectiveness of rifaximin against chronic IBS A targeted antibiotic provides effective and long-lasting relief of Irritable Bowel Syndrome symptoms, according to the results of two multisite Phase III clinical trials designed by Cedars-Sinai researchers. Rifaximin is the first drug treatment for IBS that relieves symptoms while it's being administered and continues to benefit patients after they stop taking the drug. Researchers found that...

2010-05-03 08:00:00

NEW ORLEANS, May 3 /PRNewswire/ -- Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary...

2010-03-18 14:02:28

IBS, abdominal pain more common in nurses working rotating shifts Nurses participating in shift work, especially those working rotating shifts, face a significantly increased risk of developing Irritable Bowel Syndrome (IBS) and abdominal pain compared to those working a standard day-time schedule, according to research published in the American Journal of Gastroenterology. "We know that people participating in shift work often complain of gastrointestinal symptoms such as abdominal pain,...

2010-01-27 16:24:41

Studies of the victims of the Walkerton, Ont. tainted drinking water tragedy have led researchers to discover DNA variations in genes that increase the risk of developing post-infectious irritable bowel syndrome (PI-IBS). The sheer scale of infection and the recording of the health of Walkerton's citizens gave a team of researchers a unique opportunity to study the origin of this disorder. "Although the exact cause of PI-IBS remains unknown, we now know for the first time that, in addition to...

2010-01-04 14:45:40

A Mayo Clinic research study published in the January issue of the American Journal of Gastroenterology finds that St. John's wort is not an effective treatment for irritable bowel syndrome (IBS). While antidepressants are frequently used to treat IBS, to date, no study has examined the success of using the herbal supplement St. John's wort in treating IBS. "Our study investigated if herbal antidepressants such as St. John's wort could benefit irritable bowel disease patients," says Yuri...

2009-11-23 07:30:00

THE WOODLANDS, Texas, Nov. 23 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that top-line data from its Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome (IBS) will be presented at GASTRO 2009 in London this week. Results from the study, which showed a significant improvement in IBS symptoms, will be presented by Dr. Philip M. Brown, Lexicon's senior vice president of clinical development, on November...